Researchers find new mechanism to turn on cancer-killing T cells
A new mechanism involved in the anti-cancer immune response has been identified and may have implications for targeting antigens.
CAR T-cell therapy recipient surpasses 5-year cancer-free mark
Out of treatment options, a leukemia patient tried CAR T-cell therapy. He’s now more than five years cancer-free.
Diffuse large B-cell lymphoma: What you need to know about diagnosis and treatments
Sonali Smith, MD, an expert on lymphoma, answers questions about non-Hodgkin lymphoma and discusses exciting new advances in the treatment for relapsed disease.